Back to Search Start Over

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

Authors :
S. N. Tereshchenko
M. V. Shestakova
F. T. Ageev
G. R. Galstyan
A. S. Galyavich
M. G. Glezer
I. V. Zhirov
Yu. A. Karpov
Zh. D. Kobalava
S. T. Matskeplishvili
Source :
Российский кардиологический журнал, Vol 25, Iss 5 (2020)
Publication Year :
2020
Publisher :
«FIRMA «SILICEA» LLC, 2020.

Abstract

Relationships and Activities. The Council of Experts was supported by AstraZeneca.

Details

Language :
Russian
ISSN :
15604071 and 26187620
Volume :
25
Issue :
5
Database :
Directory of Open Access Journals
Journal :
Российский кардиологический журнал
Publication Type :
Academic Journal
Accession number :
edsdoj.fcda189d1b94fcebbfc56fead0270a5
Document Type :
article
Full Text :
https://doi.org/10.15829/1560-4071-2020-3919